UnitedHealth Group (NYSE:UNH) Issues FY 2024 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 27.500-27.750 for the period, compared to the consensus earnings per share estimate of 27.610. The company issued revenue guidance of -.

UnitedHealth Group Price Performance

NYSE UNH opened at $578.97 on Friday. The firm has a market capitalization of $532.81 billion, a P/E ratio of 37.72, a PEG ratio of 1.78 and a beta of 0.58. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a 50-day moving average price of $587.48 and a 200-day moving average price of $558.34. UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the company posted $6.56 EPS. Equities research analysts anticipate that UnitedHealth Group will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.45%. UnitedHealth Group’s payout ratio is 54.72%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research reports. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, November 20th. HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Truist Financial reissued a “buy” rating and set a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday. Finally, KeyCorp initiated coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $625.26.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.